UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 7,405	$ 6,476
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	330	298
Amortization	1,031	1,179
Provision for (recovery of) losses on accounts receivable	(1)	(7)
(Gain) loss on disposal of assets	0	0
Deferred income taxes	(182)	(237)
Stock-based compensation expense	69	42
Tax benefit attributable to exercise of stock options	21	35
Changes in operating assets and liabilities:
Accounts receivable	(1,157)	(450)
Accrued interest and other receivables	(5)	(34)
Inventories	(100)	196
Prepaid expenses and other current assets	60	61
Accounts payable	68	427
Accrued expenses	203	(222)
Total adjustments	337	1,288
Net cash provided by operating activities	7,742	7,764
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(114)	(90)
Capital expenditures for intangible assets	0	(9)
Net cash provided by (used in) investing activities	(114)	(99)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	168	257
Payment of dividends	(984)	(976)
Net cash provided by (used in) financing activities	(816)	(719)
Effect of exchange rate changes on cash	629	(829)
Net increase (decrease) in cash and cash equivalents	7,441	6,117
Cash at beginning of period	26,296	23,278
Cash at end of period	33,737	29,395
Cash paid during the period for income taxes	2,676	2,422
Cash paid during the period for interest	$ 0	$ 0